| 发明名称 | Tricyclic fused ring inhibitors of hepatitis C | ||
| 摘要 | Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C. | ||
| 申请公布号 | US8999967(B2) | 申请公布日期 | 2015.04.07 |
| 申请号 | US201113877151 | 申请日期 | 2011.09.28 |
| 申请人 | Presidio Pharmaceuticals, Inc. | 发明人 | Li Leping;Zhong Min |
| 分类号 | C07D405/14;C07D413/14;C07D401/14;C07D403/14;C07D409/14;C07D417/14 | 主分类号 | C07D405/14 |
| 代理机构 | Morrison & Foerster LLP | 代理人 | Morrison & Foerster LLP |
| 主权项 | 1. A compound having a formula selected from: or a pharmaceutically acceptable salt thereof. | ||
| 地址 | San Francisco CA US | ||